KSCCM
Articles
- Page Path
- HOME > Acute Crit Care > Volume 13(2); 1998 > Article
- Case Report Successful Coronary Interventions with the Aid of Abciximab (ReoPro (R)) in High-Risk Patients: Report of Two Cases
- Woo Suck Park, Myung Ho Jeong, Nam Ho Kim, Young Keun Ahn, Youl Bae, Gwang Chae Gill, Joo Hyung Park, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang
-
DOI: https://doi.org/
1Department of Internal Medicine, Chonnam University Medical School, Kwangju, Korea. 
2The Research Institute of Medical Sciences, Chonnam National University, Kwangju, Korea.
2The Research Institute of Medical Sciences, Chonnam National University, Kwangju, Korea.
- 1,464 Views
- 10 Download
- 0 Crossref
- 0 Scopus
Abstract
Abrupt closure of coronary artery during coronary intervention is one of major limitations especially in high-risk patients. Platelets are responsible for composing acute thrombotic occlusion at the site of therapeutic arterial injury. Abciximab (platelet glycoprotein IIb/IIIa receptor blocker) might be helpful in preventing the acute thrombotic occlusion. We experienced an excellent effects of the drug in two cases of high-risk patients, unsuccessful thrombolytics and PTCA with acute occlusion. With additional use of abciximab we overcame the complications and succeeded in getting normal coronary flow and resultant successful angioplasties.
Cite
